Genetic engineering may hold key to Lyme disease vaccine

04/6/2010 | USA Today

Researchers found that deactivating one gene in the tick-borne bacteria that cause Lyme disease helped prevent mice from contracting the disease. The hope is that the research by Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention in Fort Collins, Colo., holds the key to a human vaccine.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN